H.B. Fuller (FUL) Q3 2026 earnings review
Pricing and restructuring expand margins despite continued volume erosion
H.B. Fuller reported Q3 net revenue of $938.2 million, growing 5.2% year-over-year on organic growth of 4.4%. Adjusted EBITDA printed at $186.7 million, landing just above the $185 million midpoint of the quarter's guide. Profitability stepped up cleanly, with adjusted gross margin climbing 120 basis points to 33.5% and adjusted EBITDA margin hitting 19.9%. Management tightened its full-year EBITDA and EPS ranges while maintaining midpoints, implying roughly $176 million in Q4 EBITDA.
⚖️ Verdict: ⚪ Neutral
The case is where it was — neutral — because strong execution on price and costs is currently offsetting a deteriorating volume picture. The company extracted a 7.4% price increase from the market, securing margins against supply shocks and generating record profitability rates. However, underlying volume fell 3.0%, a backward step from Q2 and a direct challenge to the earlier narrative that supply chain crises would function as a share-capture mechanism.
What the print leaves unanswered is whether the company can retain this newly established pricing floor if upstream commodity constraints ease, and whether the volume losses are cyclical or structural. The immediate test is the cash flow statement: management must unwind an elevated working capital position in Q4 to hit its unchanged cash targets before closing the AMS acquisition.
🐂 Bull Case
Pricing Execution Overcomes Volume Declines
The company's top-line performance rests entirely on pricing power. A 7.4% price increase more than offset a 3.0% decline in volume, allowing H.B. Fuller to print 4.4% organic revenue growth. This confirms the strategy telegraphed in Q1, where management pushed through minimum 10% global rate hikes to combat raw material inflation and shortages.
This discipline proves the company can defend its top line during a demand drought, but the number to watch is whether pricing holds if underlying commodity pressures ease. The full-year guidance for mid-single-digit price realization suggests management intends to retain these gains rather than index them back downward.
Restructuring Drives Margin Expansion
Pricing flowed cleanly through to profitability. Adjusted gross margins expanded by 120 basis points year-over-year to 33.5%, driven by price realization and savings from the Quantum Leap restructuring program. Adjusted EBITDA margin followed, reaching a record 19.9% and stepping closer to the company's long-term target of exceeding 20%.
Because SG&A expenses rose 8% year-over-year—partially offsetting gross margin gains—the expansion at the EBITDA line relies heavily on maintaining that gross spread. Management credits footprint consolidation and disciplined execution for the leverage, suggesting the savings are structural rather than cyclical.
🐻 Bear Case
Volume Shedding Contradicts Share-Gain Narrative
Two quarters ago, management framed supply chain disruptions from the Middle East as a rare opportunity to seize market share from competitors lacking H.B. Fuller's sourcing infrastructure. The volume prints tell a different story: organic volume declined 3.0% this quarter, worsening from a 0.4% decline in Q2. If the company is winning durable new business, it is being entirely masked by erosion in the base.
The company maintains its full-year guidance for volumes to be down low-single digits. Until volume turns positive, the narrative that the crisis served as an industry share reset remains unsupported by the printed flows.
Strategic Inventory Drags on Working Capital
Supply chain defense comes at a direct cost to cash efficiency. Net working capital expanded to 18.5% of annualized net revenue, up 150 basis points from a year ago. Management points to strategic inventory investments required to support the Quantum Leap footprint optimization and buffer against ongoing Middle East logistics disruptions.
This build caps operating cash flow realization. While year-to-date operating cash flow is up 17% year-over-year, hitting the unchanged $300–$325 million full-year target will require unwinding this defensive inventory position in Q4.
👓 Other Themes
Returning to the M&A Engine
After pausing acquisitions earlier in the year to prioritize debt paydown and share repurchases, management explicitly flagged the anticipated closing of the AMS acquisition before year-end. This signals a return to using M&A as a primary EBITDA compounder, a core element of the historical strategy.
💲 Other KPIs
Flipped to positive 6.4% organic growth this quarter, compared to a 3.1% decline in the prior-year period, establishing it as the fastest-growing segment in Q3.
Grew 5.2% organically, up from flat organic sales a year ago and navigating an uneven global construction environment.
Improved from 3.3x a year ago and sits at the top end of the company's long-term targeted 2.5x to 3.0x range.
🔮 Guidance
Maintained the full-year view for top-line growth. Organic revenue remains guided to low-single digits, structured as mid-single-digit pricing offsetting low-single-digit volume declines. Foreign exchange is expected to add roughly 2%.
Tightened the range while effectively holding the midpoint ($662.5 million). This implies Q4 adjusted EBITDA of approximately $176 million (derived), supporting continued margin expansion into the close of the year.
Narrowed the band symmetrically, securing the bottom end of the range while shaving the top. Implies Q4 adjusted EPS of approximately $1.28 at the midpoint (derived).
Excluding AMS-related items, the cash target is preserved. Hitting it requires normalizing the strategic inventory built up in Q3 over the final quarter.
Lowered from the prior expectations laid out at the end of fiscal 2025.
❓ Key Questions
Unpacking the Volume Decline
With organic volume dropping 3.0% in Q3—a deceleration from Q2—how much of this contraction is deliberate deselection of lower-margin business versus core demand destruction?
Inventory Unwind Mechanics
Net working capital sits at 18.5% of revenue due to defensive supply chain posturing. What is the precise mechanism and timeline for unwinding this build to hit the $300–$325 million operating cash flow target in Q4?
AMS Integration Profile
As the AMS acquisition nears closing, what is the anticipated margin profile on Day 1, and how quickly will it begin contributing to the 20% long-term EBITDA margin goal?